MFC
Manulife Financial Corporation
There isn't enough reported data to score MFC yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
MFC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
MFC's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like MFC.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
MFC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $17.83 | -59% |
| Fair | 9x | $23.36 | -47% |
| Expensive | 16x | $41.54 | -5.4% |
| Current | 17x | $43.92 | — |
Historical ranges are pointers, not guarantees.
MFC's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over MFC in the historical PE scenario, which offers more potential upside but is not a forecast.
MFC Forward outlook
There aren't enough analyst estimates for MFC to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
MFC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.59 | +19% |
| Q1 2026 | $2.43 | +31% |
| Q4 2025 | $2.16 | +8.5% |
| Q3 2025 | $2.19 | +10% |
| Q2 2025 | $2.17 | +32% |
| Q1 2025 | $1.85 | +13% |
| Q4 2024 | $1.99 | +8.7% |
| Q3 2024 | $1.99 | +4.7% |
MFC's earnings per share have climbed steadily: $2.59 over the past year, up 19% from the year before, and higher year over year for eight quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over MFC on earnings, with stronger typical year-over-year growth.
MFC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.9B | -52% |
| Q1 2026 | $8.7B | +36% |
| Q4 2025 | $6B | +104% |
| Q3 2025 | $12.2B | +19% |
| Q2 2025 | $28.9B | +123% |
| Q1 2025 | $6.4B | -74% |
| Q3 2024 | $10.2B | -27% |
| Q2 2024 | $13B | -20% |
MFC's revenue has slid since its 2025 peak: $13.9B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +8.6 points |
| Q1 2026 | 12% | +4.2 points |
| Q4 2025 | 22% | -28 points |
| Q3 2025 | 13% | -3.2 points |
| Q2 2025 | 5.5% | -2 points |
| Q1 2025 | 7.7% | +4.2 points |
| Q4 2024 | 50% | N/A |
| Q3 2024 | 16% | +10 points |
MFC's operating margin was 14% last quarter, up 8.6 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over MFC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over MFC on profitability, with a higher operating margin.
MFC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.4B | +25% |
| Q1 2026 | $2.5B | -47% |
| Q4 2025 | $6B | +21% |
| Q3 2025 | $6.7B | +27% |
| Q2 2025 | $5.1B | 0% |
| Q1 2025 | $4.7B | +46% |
| Q4 2024 | $5B | +16% |
| Q3 2024 | $5.3B | +37% |
MFC has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
MFC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -38M shares |
| 1 year | -2.6% | -45M shares |
| 3 years | -11% | -210M shares |
| 5 years | -14% | -276M shares |
| Available history | -15% | -288M shares |
MFC has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $421.1M |
| Q1 2026 | $261.5M |
| Q4 2025 | $240.2M |
| Q3 2025 | $431M |
| Q2 2025 | $459.1M |
| Q1 2025 | $356.4M |
| Q4 2024 | $1B |
| Q3 2024 | $693.2M |
MFC spent $1.4B buying back its own shares over the past year, down 46% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
MFC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
MFC has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
MFC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.1 | Neutral |
| Stochastic | 56.6 | Neutral |
MFC's weekly RSI is 58 (neutral) and its Stochastic is 57 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
MFC PE vs Financial Services Sector
| Metric | MFC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 13x | 30% above |
| PE % | 94 | 63 | 31 pts above |
MFC is trading at 17x earnings, a 30% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over MFC on valuation relative to its sector.
MFC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.7 | 0.5% above |
| 20 week MA | $43.5 | 1% above |
| 50 week MA | $39.7 | 11% above |
| 100 week MA | $35.4 | 24% above |
| 200 week MA | $29.1 | 51% above |
MFC has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
MFC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.1 | $17.5 | -13% |
| 2021 | $17.5 | $18.7 | +6.8% |
| 2022 | $18.7 | $17.9 | -4.4% |
| 2023 | $17.9 | $22.1 | +24% |
| 2024 | $22.1 | $30.7 | +39% |
| 2025 | $30.7 | $36.6 | +19% |
| 2026 YTD | $36.6 | $43.9 | +20% |
MFC has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.